Curative in particular is focusing on the spinal fusion, osteoporosis and osteoarthritis markets, which we feel are the three largest growth segments of the orthopedics market.

Who We Are
Curative Bioscience Corporation based in Waltham, Massachusetts is poised to become a leader in the development and commercialization of biologic products that leverage the company’s exciting peptide and peptidomimetic technology. Curative Bioscience peptide development initiatives are focused on utilization and customization of novel biomaterials and biologics to develop transformational products that address the repair and healing of bone and cartilage that has been damaged as a result of age associated degeneration. Curative in particular is focusing on the spinal fusion, osteoporosis and osteoarthritis markets, which we feel are the three largest growth segments of the orthopedics market.

The Market Dynamics
The orthopedic sector of medicine is among the largest and fastest growing sectors in medical technology. This sector has been long dominated by metallic implants, but the trend toward treating orthopedic disease with biologics and biomaterials is among the most important directional changes in the orthopedic industry. The advancement in age of the large baby boomer population and the inefficiency of current hardware products will form a nexus for a rise in the popularity of reparative synthetics.

The Curative Bioscience Advantage
Curative’s core strength lies in its development of treatments for regenerative medicine and its successful integration of three core competencies in advanced biomaterials, biologics and engineering. The Curative product pipeline is aligned with this movement toward biological solutions that address the growing need for simple technology to treat an aging yet active global population that is prone to orthopedic and degenerative disease. These products, used alone or in combination configurations, promote the repair and natural healing of human bone, skeletal, and soft tissues such as cartilage and cancellous bone. The advancement in age of the baby boomer generation and the popularity of reparative devices will make the necessity of treating the symptomatic presentation of osteoporosis and osteoarthritis even more critical, presenting what we believe is one of the most significant market opportunities in orthopedics. It has put Curative on the cutting edge of the regenerative medicine revolution.

5-21-08